Remibrutinib: First Approval
Fields of Study & Subjects
Urticaria and Related Conditions
Autoimmune Bullous Skin Diseases
Spondyloarthritis Studies and Treatments
Publication details
- Journal / source
- Drugs
- Publisher
- Springer Science and Business Media LLC
- Volume
- 86
- Issue
- 3
- Pages
- 403–410
- Publication date
- 21 January 2026
- Language
- EN